Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      ERT Reports Second Quarter 2011 Operating Results

      - Revenues of $42.8 million

      - GAAP diluted net income per share of $0.04 / Non-GAAP diluted net income per share of $0.06

      - Bookings of $70.9 million

      - Backlog of $333.2 million


      News provided by

      ERT

      Aug 01, 2011, 04:05 ET

      Share this article

      Share this article


      PHILADELPHIA, Aug. 1, 2011 /PRNewswire/ -- eResearchTechnology, Inc. (ERT), (Nasdaq: ERT) a global technology-driven provider of services and customizable medical devices to biopharmaceutical and healthcare organizations and the market leader for centralized cardiac safety and respiratory efficacy services in drug development, announced today results for the second quarter ended June 30, 2011.  Unless otherwise noted, all comparative numbers refer to changes from the same period a year ago.  The financial results include the results related to CareFusion Research Services (RS and now included as part of our German operations) commencing from its date of acquisition on May 28, 2010.  

      This press release contains financial measures prepared in accordance with accounting principles generally accepted in the United States ("GAAP") and non-GAAP measures adjusted to exclude the impact of the amortization of the acquired intangibles and other assets and acquisition and other costs related to the RS acquisition and related income tax effects.  A reconciliation of these GAAP and non-GAAP measures is found in the attached "Reconciliation of GAAP to Non-GAAP Information."

      Financial Highlights for the Second Quarter of 2011

      • Net revenues were $42.8 million for the second quarter of 2011 compared to $41.7 million for the first quarter of 2011 and $29.1 million a year ago.  Revenues from our German operations were $20.3 million in the second quarter of 2011, compared to $18.9 million in the first quarter of 2011 and $5.7 million a year ago, which comprised only the month of June.

      • GAAP gross margin percentage was 37.4% in the second quarter of 2011 compared to 44.2% for the first quarter of 2011 and 54.4% a year ago.  Non-GAAP gross margin percentage was 42.0% in the second quarter of 2011 compared to 48.7% for the first quarter of 2011 and 57.2% a year ago.  Gross margins were negatively impacted this quarter by increased costs in our German operations including incremental labor, consumables and freight charges to support the start of new respiratory studies, negative manufacturing variances and a $0.5 million non-cash adjustment to the carrying value of returned rental equipment as of March 2011 that was recorded in the June 2011 quarter.

      • GAAP operating income margin percentage was 6.0% in the second quarter of 2011 compared to 12.8% for the first quarter of 2011 and 3.6% a year ago.  Non-GAAP operating income margin percentage was 10.6% in the second quarter of 2011 compared to 17.3% for the first quarter of 2011 and 19.7% a year ago.

      • GAAP net income was $1.8 million, or $0.04 per diluted share, in the second quarter of 2011 compared to $3.1 million, or $0.06 per diluted share, in the first quarter of 2011 and $0.8 million, or $0.02 per diluted share, a year ago.  Non-GAAP net income was $3.0 million, or $0.06 per diluted share, in the second quarter of 2011 compared to $4.5 million, or $0.09 per diluted share, in the first quarter of 2011 and $4.0 million, or $0.08 per diluted share, a year ago.

      • Cash flow from operations was $8.7 million in the second quarter of 2011, compared to $5.0 million in the first quarter of 2011 and $7.1 million a year ago.

      • Cash and short-term investments totaled $31.7 million at June 30, 2011 compared to $29.7 million on March 31, 2011.  ERT had $21.0 million in long-term debt as of June 30, 2011 and March 31, 2011.

      • New bookings were $70.9 million in the second quarter of 2011 compared to $71.8 million for the first quarter of 2011 and $51.0 million a year ago.  

      • The gross book-to-bill ratio was 1.7 in the second quarter of 2011 compared to 1.7 in the first quarter of 2011 and 1.8 a year ago.  

      • Backlog was $333.2 million as of June 30, 2011 compared to $318.6 million as of March 31, 2011 and $299.4 million a year ago.  The annualized cancellation rate was 13.4% in the second quarter of 2011 compared to 24.6% in the first quarter of 2011 and 9.7% a year ago.  

      Financial highlights for the first six months of 2011

      • Net revenues were $84.5 million for the first six months of 2011 compared to $51.0 million in the comparable period a year ago.  Revenues from RS from the date of acquisition to June 30, 2010 were $5.7 million and $39.2 million for the first six months of 2011.

      • GAAP Gross margin percentage was 40.8% in the first six months of 2011 compared to 54.1% for the comparable period a year ago.  Non-GAAP gross margin percentage was 45.3% in the first six months of 2011 compared to 55.7% for the comparable period a year ago.  

      • GAAP operating income margin percentage was 9.4% in the first six months of 2011 compared to 7.5% in the comparable period a year ago.  Non-GAAP operating income margin percentage was 13.9% in the first six months of 2011 compared to 18.1% for the comparable period a year ago.  

      • GAAP net income was $4.9 million, or $0.10 per diluted share, in the first six months of 2011 compared to $2.6 million, or $0.05 per diluted share, in the comparable period a year ago.  Non-GAAP net income was $7.5 million, or $0.15 per diluted share, in the first six months of 2011 compared to $6.3 million, or $0.13 per diluted share, in the comparable period a year ago.  

      • Cash flow from operations was $13.7 million in the first six months of 2011 compared to $12.4 million in the comparable period a year ago.

      • New bookings were $142.7 million in the first six months of 2011 compared to $94.2 million for the first six months of 2010.  

      "We are pleased to have completed our second consecutive quarter where bookings exceeded $70 million," commented Dr. Jeffrey Litwin, President and Chief Executive Officer of ERT.   "Bookings this quarter were driven by strengthening cardiac safety and very strong electronic Patient Reported Outcome (ePRO) activity.   Our revenue level was slightly lower than expected due to the delay in start time of two major studies, however revenue is projected to be stronger over the next two quarters given our present backlog.  We are disappointed with our 6.8 percentage point sequential drop in gross profit margin from our March 2011 quarter.  My focus has been on top line revenue growth and we made decisions to increase staffing and expedite product manufacturing in our German operations to meet aggressive study timelines for key strategic customers in our respiratory and ePRO business lines which impacted costs.  During the current quarter we started several large new respiratory studies which incurred higher costs for study set up, customization and costs to expedite product manufacturing which resulted in higher freight, consumables and manufacturing variances.   We expect gross profit margins to improve in the coming quarter as a portion of these charges incurred the German operations are not expected to be recurring and projected increases in revenue should generate higher margins given the operating leverage in our cost structure. "

      2011 Guidance

      ERT modified its guidance for the full year of 2011.  ERT expects net revenues of between $178 million and $183 million for 2011 with the top end of the range reduced from prior guidance of $188 million.  ERT expects GAAP diluted net income per share to be between $0.27 and $0.32 for 2011 and non-GAAP diluted net income per share to be between $0.37 and $0.42 for the same period.   EPS guidance has been reduced to reflect a drop in the range of the revenue guidance and the lower than expected results for the June 2011 quarter.

      For the third quarter ending September 30, 2011, ERT expects net revenues of between $46.0 million and $49.0 million, GAAP diluted net income per share to be between $0.08 and $0.11 and non-GAAP diluted net income per share to be between $0.11 and $0.14.    

      Use of Non-GAAP Financial Measures

      In addition to GAAP financial measures, ERT uses certain non-GAAP financial measures that exclude charges related to the amortization of the RS acquired intangible and other assets and acquisition and other costs which are related to the RS acquisition, and also their related income tax effects.  ERT believes that these non-GAAP measures are useful to investors because this supplemental information facilitates comparisons of its operations from period to period and to the performance of other companies within its industry and assists in gaining a better understanding of its operating results and future prospects.  ERT views amortization of acquired intangible and other assets related to the RS acquisition, which includes such items as the amortization of acquired customer backlog and technology, as items determined at the time of the acquisition.  While ERT reviews the underlying value of these intangibles regularly for impairment, the amortization is an expense typically not affected by operations during any particular period and does not contribute to the operational performance in any particular period.  ERT regards acquisition and other costs related to its recent acquisition as a cost that does not recur on a regular basis.  

      ERT's non-GAAP effective tax rates differ from its GAAP effective tax rates because of 1) the exclusion of the amortization of acquired intangible and other assets and acquisition and other costs related to its acquisition of RS and 2) the income tax effect due to the difference between the GAAP and non-GAAP effective tax rate applied against the GAAP pre-tax income, primarily as a result of the acquisition costs incurred in 2010 not being deductible for income tax purposes.  ERT excludes the impact of these discrete tax items from its non-GAAP income tax provision because it believes they are not indicative of the effective income tax rate of its ongoing business operations.

      Management uses these non-GAAP financial measures, in addition to the measures prepared in accordance with GAAP, as the basis for measuring ERT's operating performance, financial and operating decision-making, developing budgets and comparing such performance to that of prior periods for the same reasons stated above.  These non-GAAP financial measures are not meant to be considered superior to or a substitute for comparable financial measures prepared in accordance with GAAP.  There are also limitations on the non-GAAP measures, including: 1) these non-GAAP measures do not have standardized meanings and may not be comparable to similar non-GAAP measures used by other companies, 2) acquisition and other costs related to ERT's 2010 acquisition of RS represent actual cash expenditures that are excluded from ERT's non-GAAP measures and 3) although amortization of acquired intangible and other assets does not directly impact ERT's current cash position, such expense is amortized over their expected economic lives and does represent the declining value of the assets acquired, but this expense is excluded from ERT's non-GAAP measures.  ERT adjusts for these limitations by relying on these non-GAAP measures only as a supplement to its GAAP results.

      Conference Call

      Dr. Litwin and Mr. Keith Schneck, the Company's Chief Financial Officer, will hold a conference call to discuss these results.  The conference call will take place at 5:00 PM EDT on August 1, 2011.  For the conference call, interested participants should dial 1-800-860-2442 when calling within the United States or 1-412-858-4600 when calling internationally. There will be a playback available as well. To listen to the playback, please call 1-877-344-7529 when calling within the United States or 1-412-317-0088 when calling internationally.  Conference code for playback is 10002497.

      This call is being webcast by MultiVu and can be accessed at ERT's website at www.ert.com. The webcast may also be accessed via the direct link at http://www.videonewswire.com/event.asp?id=81200. The webcast can be accessed for up to one year on either site.  

      About eResearchTechnology, Inc.

      ERT (www.ert.com) is a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations.  It is the market leader for centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic patient reported outcomes (ePRO) in multiple modalities across all phases of clinical research.

      This release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect our current views as to future events and financial performance with respect to our operations.  These statements can be identified by the fact that they do not relate strictly to historical or current facts.  They use words such as "aim," "anticipate," "are confident," "estimate," "expect," "will be," "will continue," "will likely result," "project," "intend," "plan," "believe," "look to" and other words and terms of similar meaning in conjunction with a discussion of future operating or financial performance.  

      These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements.  Factors that might cause such a difference include: unfavorable economic conditions; our ability to obtain new contracts and accurately estimate net revenues, our positive outlook for future bookings, variability in size, scope and duration of projects and internal issues at the sponsoring client; our ability to successfully integrate the RS or any future acquisitions; competitive factors in the market for our centralized services; changes in the bio-pharmaceutical and healthcare industries to which we sell our solutions; technological development; and market demand.  There is no guarantee that the amounts in our backlog will ever convert to revenue.  Should the economic conditions deteriorate, the cancellation rates that we have historically experienced could increase.  Further information on potential factors that could affect the Company's financial results can be found in ERT's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission.  Guidance is based on management's good faith expectations given current market conditions but that continued or further deterioration of general economic conditions, in addition to other factors cited elsewhere, could result in ERT not achieving the revenue and net income per diluted share guidance provided.

      Forward-looking statements speak only as of the date made.  We undertake no obligation to update any forward-looking statements, including prior forward-looking statements, to reflect the events or circumstances arising after the date as of which they were made.  As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included in this release or that may be made in our filings with the Securities and Exchange Commission or elsewhere from time to time by, or on behalf of, us.

      Contact:


      Keith Schneck    

      Robert East

      eResearchTechnology, Inc.  

      Westwicke Partners, LLC

      215-282-5566  

      443-213-0502




      eResearchTechnology, Inc. and Subsidiaries


      Consolidated Statements of Operations


      (in thousands, except per share amounts)


      (unaudited)






















      Three Months Ended June 30,


      Six Months Ended June 30,






      2010



      2011


      2010



      2011













      Net revenues:














      Services



      $          18,697



      $          22,416


      $          33,532



      $         46,393



      Site support



      10,399



      20,433


      17,432



      38,155
















      Total net revenues



      29,096



      42,849


      50,964



      84,548
















      Costs of revenues:














      Cost of services



      8,325



      13,615


      15,636



      26,771



      Cost of site support



      4,957



      13,189


      7,756



      23,312
















      Total costs of revenues



      13,282



      26,804


      23,392



      50,083
















      Gross margin



      15,814



      16,045


      27,572



      34,465
















      Operating expenses:














      Selling and marketing



      3,941



      4,426


      7,349



      8,601



      General and administrative



      9,753



      7,247


      14,498



      14,755



      Research and development



      1,069



      1,802


      1,927



      3,185
















      Total operating expenses



      14,763



      13,475


      23,774



      26,541
















      Operating income



      1,051



      2,570


      3,798



      7,924


      Foreign exchange gains (losses)



      399



      (266)


      479



      (1,275)


      Other (expense) income, net



      (3)



      (168)


      17



      (269)
















      Income before income taxes



      1,447



      2,136


      4,294



      6,380


      Income tax provision



      621



      355


      1,716



      1,506
















      Net income



      $               826



      $            1,781


      $            2,578



      $           4,874
















      Net income per share:














      Basic



      $              0.02



      $              0.04


      $              0.05



      $             0.10



      Diluted



      $              0.02



      $              0.04


      $              0.05



      $             0.10
















      Shares used in computing net income per share:














      Basic



      48,831



      49,146


      48,753



      49,021



      Diluted



      49,383



      49,330


      49,114



      49,291



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Balance Sheets

      (in thousands, except share and per share amounts)

      (unaudited)



















      December 31, 2010


      June 30, 2011

      ASSETS
















      Current assets:








          Cash and cash equivalents



      $                30,343




      $               31,601

          Short-term investments



                               50




                              50

          Investment in marketable securities



                             648




                            972

          Accounts receivable less allowance for doubtful accounts








               of $515 and $555, respectively



                        37,236




                       34,525

          Inventory



                          4,698




                       10,893

          Prepaid income taxes



                          1,988




                         3,216

          Prepaid expenses and other



                          4,393




                         5,886

          Deferred income taxes



                          3,431




                         3,431

              Total current assets



                        82,787




                       90,574









      Property and equipment, net



                        42,615




                       47,767

      Goodwill



                        71,637




                       77,357

      Intangible assets



                        17,187




                       15,702

      Other assets



                             609




                            680









                 Total assets



      $              214,835




      $             232,080









      LIABILITIES AND STOCKHOLDERS' EQUITY
















      Current liabilities:








          Accounts payable



      $                  7,136




      $                 5,569

          Accrued expenses



                        16,162




                       13,731

          Deferred revenues



                        11,670




                       13,588

              Total current liabilities



                        34,968




                       32,888









      Deferred rent



                          2,368




                         2,397

      Deferred income taxes



                          3,703




                         4,098

      Long-term debt



                        21,000




                       21,000

      Other liabilities



                          2,141




                         2,146









                 Total liabilities



                        64,180




                       62,529









      Stockholders' equity:








          Preferred stock-$10.00 par value, 500,000 shares authorized,








               none issued and outstanding



                               -  




                              -  

          Common stock-$.01 par value, 175,000,000 shares authorized,








               60,460,782 and 60,807,913 shares issued, respectively



                             605




                            608

          Additional paid-in capital



                      100,441




                     102,548

          Accumulated other comprehensive (loss) income



                        (1,545)




                       10,413

          Retained earnings



                      131,037




                     135,911

          Treasury stock, 11,589,603 and 11,596,966 shares at cost



                      (79,883)




                     (79,929)









              Total stockholders' equity



                      150,655




                     169,551









                 Total liabilities and stockholders' equity



      $              214,835




      $             232,080



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Statements of Cash Flows

      (in thousands)

      (unaudited)






      Six Months Ended June 30,





      2010


      2011








      Operating activities:







        Net income




      $           2,578


      $           4,874

        Adjustments to reconcile net income to net cash







            provided by operating activities:







                Depreciation and amortization




                   6,307


                 12,460

                Cost of sales of equipment




                          4


                          8

                Share-based compensation




                   1,425


                   1,421

                Deferred income taxes




                      216


                      413

                Loss on disposal of equipment




                        -  


                      780

                Changes in operating assets and liabilities:







                   Accounts receivable




                 (1,722)


                   3,648

                   Inventory




                    (436)


                 (4,973)

                   Prepaid expenses and other




                    (925)


                 (1,761)

                   Accounts payable




                   1,227


                 (1,002)

                   Accrued expenses




                   4,925


                 (2,624)

                   Income taxes




                 (1,120)


                 (1,288)

                   Deferred revenues




                      102


                   1,738

                   Deferred rent




                    (204)


                        23

                       Net cash provided by operating activities




                 12,377


                 13,717








      Investing activities:







        Purchases of property and equipment




                 (8,773)


               (14,754)

        Purchases of investments




                    (999)


                        -  

        Proceeds from sales of investments




                 10,731


                        -  

        Payments for acquisitions




               (80,475)


                    (117)

                       Net cash used in investing activities




               (79,516)


               (14,871)








      Financing activities:







        Proceeds from long-term debt




                 23,000


                        -  

        Proceeds from exercise of stock options




                      205


                      629

        Stock option income tax benefit




                        12


                        12

        Repurchase of common stock for treasury




                        -  


                      (46)

                       Net cash provided by financing activities




                 23,217


                      595








      Effect of exchange rate changes on cash




                 (2,553)


                   1,817








      Net (decrease) increase in cash and cash equivalents




               (46,475)


                   1,258

      Cash and cash equivalents, beginning of period




                 68,979


                 30,343








      Cash and cash equivalents, end of period




      $         22,504


      $         31,601



      eResearchTechnology, Inc. and Subsidiaries

      Reconciliation of GAAP to Non-GAAP Information

      (in thousands, except per share amounts)

      (unaudited)



      Three Months Ended


      Six Months Ended











      June 30,   2010

      March 31, 2011

      June 30,   2011


      June 30,    2010

      June 30,    2011

      Net revenues


      $              29,096

      $              41,699

      $              42,849


      $               50,964

      $               84,548









      Reconciliation of GAAP to Non-GAAP gross margin:








      GAAP gross margin


      $              15,814

      $              18,420

      $              16,045


      $               27,572

      $               34,465

      Amortization of acquired intangibles and other assets


      833

      1,878

      1,970


      833

      3,848

      Non-GAAP gross margin


      $              16,647

      $              20,298

      $              18,015


      $               28,405

      $               38,313

      Non-GAAP gross margin percentage


      57.2%

      48.7%

      42.0%


      55.7%

      45.3%

      Non-GAAP gross margin percentage is calculated by dividing non-GAAP gross margin by net revenues





      -








      Reconciliation of GAAP to Non-GAAP








          operating income:








      GAAP operating income


      $                1,051

      $                5,354

      $                2,570


      $                 3,798

      $                 7,924

      Amortization of acquired intangibles and other assets


      833

      1,878

      1,970


      833

      3,848

      Acquisition and integration related costs


      3,840

      -

      -


      4,581

      -

      Non-GAAP operating income


      $                5,724

      $                7,232

      $                4,540


      $                 9,212

      $               11,772

      Non-GAAP operating income margin percentage


      19.7%

      17.3%

      10.6%


      18.1%

      13.9%

      Non-GAAP operating income margin percentage is calculated by dividing non-GAAP operating income by net revenues




      -








      Reconciliation of GAAP to Non-GAAP net income:








      GAAP net income


      $                   826

      $                3,093

      $                1,781


      $                 2,578

      $                 4,874

      Amortization of acquired intangibles and other assets


      833

      1,878

      1,970


      833

      3,848

      Acquisition and integration related costs


      3,840

      -

      -


      4,581

      -

      Income tax effect due to Non-GAAP reconciling items
      and other differences between the GAAP and
      Non-GAAP effective tax rate


      (1,529)

      (502)

      (754)


      (1,689)

      (1,256)

      Non-GAAP net income


      $                3,970

      $                4,469

      $                2,997


      $                 6,303

      $                 7,466

      -








      Reconciliation of GAAP to Non-GAAP diluted








          net income per share:








      GAAP diluted net income per share


      $                  0.02

      $                  0.06

      $                  0.04


      $                   0.05

      $                   0.10

      Amortization of acquired intangibles and other assets


      0.02

      0.04

      0.04


      0.02

      0.08

      Acquisition and integration related costs


      0.08

      -

      -


      0.09

      -

      Income tax effect due to Non-GAAP reconciling items
      and other differences between the GAAP and
      Non-GAAP effective tax rate


      (0.04)

      (0.01)

      (0.02)


      (0.03)

      (0.03)

      Non-GAAP diluted net income per share


      $                  0.08

      $                  0.09

      $                  0.06


      $                   0.13

      $                   0.15









      Shares used in computing diluted net income per share


      49,383

      49,251

      49,330


      49,114

      49,291

      Assumed effective tax rate - Non-GAAP


      35.0%

      27.0%

      27.0%


      35.0%

      27.0%









      -












      Three Months

      Year



      Ending September 30, 2011

      Ending December 31, 2011



      Low Range


      High Range


      Low Range

      High Range

      Reconciliation of GAAP to Non-GAAP








          diluted net income per share guidance:








      GAAP estimate of diluted net income per share


      $                  0.08


      $                  0.11


      $                   0.27

      $                   0.32

      Estimated effect on diluted net income per share of:








          Amortization of acquired intangibles and other assets


                          0.04


                          0.04


                           0.15

                           0.15

          Income tax effect due to Non-GAAP reconciling items
               and other differences between the GAAP and
               Non-GAAP effective tax rate


                        (0.01)


                        (0.01)


                         (0.05)

                         (0.05)

      Non-GAAP estimate of diluted net income per share


      $                  0.11


      $                  0.14


      $                   0.37

      $                   0.42









      Shares used in computing estimated diluted net income per
          share


                      49,500


                      49,500


                       49,303

                       49,303

      Effective tax rate


      27.0%


      27.0%


      27.0%

      27.0%



      SOURCE ERT

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.